Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
The US Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals' Livsayis (cemdisiran) to treat generalised myasthenia gravis (gMG) in …
Biogen has reported two-year data from its Phase II CELIA trial showing that diranersen (BIIB080) slowed clinical decline in early …
Masimo has secured US Food and Drug Administration (FDA) clearance for its smartSedLine brain function monitoring system, marking the Danaher …
The European Commission (EC) has granted marketing authorisation for Revolution Medicines’ Rasonque (daraxonrasib) to treat adult patients with metastatic pancreatic …
MSD has discontinued its Phase III BELLWAVE-011 trial assessing nemtabrutinib (MK-1026) for leukaemia and other haematologic malignancies after an external …
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
Science Corporation has raised $400m to expand the rollout of its Prima retinal implant system across Europe and prepare for …
Eli Lilly has agreed to acquire Calytrix Bio in a deal valued at up to $1.5bn to advance an investigational …
Rein Therapeutics has reported preliminary blinded 12-week findings from the Phase II RENEW clinical study of its lead drug, LTI-03, …
The US Food and Drug Administration (FDA) has granted de novo authorisation to Roche’s cobas pro i 601 platform alongside …
The US Food and Drug Administration (FDA) has declined to approve Summit Therapeutics’ biologics licence application (BLA) for ivonescimab in …
Novo Nordisk has reported post hoc findings from the Phase III REDEFINE 1 trial evaluating its investigational combination therapy CagriSema …
The US Food and Drug Administration (FDA) has cleared Molecular Designs' SimplicityDx FluA/FluB/RSV panel, marking the company's first cleared diagnostic …
Japanese pharma major Takeda has commercially launched Orzeyful (oveporexton) in the US for the treatment for adult patients with narcolepsy …
Vasa Therapeutics has reported positive topline findings demonstrating clinical proof of concept for its lead therapy, VS-041, in a Phase …
Medical technology firm Ventric Health has agreed to a partnership with pharmacy services provider Stellus Rx to connect outpatient heart …